Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | 455 | 663 | 653 | 3,322 | 487 |
| Gross Profit | 455 | 663 | 653 | 3,322 | 487 |
| Operating Expenses | 3,203 | 4,765 | 3,999 | 5,133 | 5,513 |
| Operating Income | -2,749 | -4,102 | -3,346 | -1,811 | -5,027 |
| Interest Expense | -97 | 0 | 0 | 0 | 0 |
| Other Income | 307 | 79 | 324 | 786 | 2,332 |
| Pre-tax Income | -2,344 | -4,024 | -3,022 | -1,026 | -2,695 |
| Net Income Continuous | -2,344 | -4,024 | -3,022 | -1,026 | -2,695 |
| Net Income | $-2,344 | $-4,024 | $-3,022 | $-1,026 | $-2,695 |
| EPS Basic Total Ops | -2.40 | -4.32 | -3.36 | -0.96 | -2.88 |
| EPS Basic Continuous Ops | -2.56 | -4.40 | -3.31 | -0.82 | -2.96 |
| EPS Diluted Total Ops | -2.40 | -4.32 | -3.36 | -0.96 | -2.88 |
| EPS Diluted Continuous Ops | -2.56 | -4.40 | -3.31 | -0.82 | -2.96 |
| EBITDA(a) | $-2,517 | $-3,863 | $-3,107 | $-1,557 | $-4,791 |